Physician profile
Julia Altmann
NPI 1043471808
$863.89
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $521 · 2020: $117 · 2021: $62.89 · 2022: $96.55 · 2024: $65.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $65.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $65.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $215.41 | 2019-2021 | |
| Merz North America, INC. | $125.83 | 2019 | |
| Abbvie INC. | $121.31 | 2021-2024 | |
| Novartis Pharmaceuticals Corporation | $82.66 | 2019 | |
| Depuy Synthes Sales INC. | $56.51 | 2022 | |
| Avanir Pharmaceuticals, INC. | $41.95 | 2019 | |
| Lilly USA, LLC | $39.28 | 2020 | |
| Abbott Laboratories | $37.14 | 2019 | |
| Daiichi Sankyo INC. | $21.30 | 2019 | |
| Bausch Health US, LLC | $19.98 | 2019 | |
| Zyla Life Sciences, INC. | $19.85 | 2019 | |
| Genzyme Corporation | $19.23 | 2019 | |
| Mdd US Operations, LLC | $16.85 | 2020 | |
| Vertical Pharmaceuticals, LLC | $15.95 | 2019 | |
| Boston Scientific Corporation | $15.82 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biodelivery Sciences International, INC. | $14.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Altmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.